Structure

InChI Key QBYUNVOYXHFVKC-GBURMNQMSA-N
Smile C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C
InChI
InChI=1S/C26H45NO5S/c1-17(4-9-24(29)27-14-15-33(30,31)32)21-7-8-22-20-6-5-18-16-19(28)10-12-25(18,2)23(20)11-13-26(21,22)3/h17-23,28H,4-16H2,1-3H3,(H,27,29)(H,30,31,32)/t17-,18-,19-,20+,21-,22+,23+,25+,26-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C26H45NO5S
Molecular Weight 483.72
AlogP 4.43
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 7.0
Polar Surface Area 103.7
Molecular species ACID
Aromatic Rings 0.0
Heavy Atoms 33.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Amyotrophic Lateral Sclerosis 3 D000690 ClinicalTrials
Liver Cirrhosis, Biliary 3 D008105 ClinicalTrials
Diabetes Mellitus, Type 1 2 D003922 ClinicalTrials
Asthma 1 D001249 ClinicalTrials
Multiple Sclerosis 1 D009103 ClinicalTrials
Liver Cirrhosis 0 D008103 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEBI 36259
ChEMBL CHEMBL408701
Guide to Pharmacology 4548
KEGG C02592
SureChEMBL SCHEMBL364160
ZINC ZINC000004095893